TRADES
Latest Trades
2087
results found
FUND
DATE
ACTION
TICKER
COMPANY
SHARES
% of ETF
ARKG 7 Oct 2021 Sell IOVA IOVANCE BIOTHERAPEUTICS INC 55,551 0.0200
ARKG 7 Oct 2021 Buy DYNS DYNAMICS SPECIAL PURPOSE CORP 202 0.0000
ARKG 7 Oct 2021 Sell CRBU CARIBOU BIOSCIENCES INC 96 0.0000
ARKG 7 Oct 2021 Sell CLLS CELLECTIS SA 55,460 0.0100
ARKG 6 Oct 2021 Sell VRTX VERTEX PHARMACEUTICALS INC 67,671 0.1800
ARKG 6 Oct 2021 Buy SURF SURFACE ONCOLOGY INC 179,161 0.0200
ARKG 6 Oct 2021 Sell SMFR SEMA4 HOLDINGS CORP 626,139 0.0700
ARKG 6 Oct 2021 Buy SLGC SOMALOGIC INC 303,876 0.0500
ARKG 6 Oct 2021 Sell SDGR SCHRODINGER INC/UNITED STATES 22,860 0.0200
ARKG 6 Oct 2021 Sell REGN REGENERON PHARMACEUTICALS INC 30,723 0.2500
ARKG 6 Oct 2021 Buy QSI QUANTUM-SI INC 120,419 0.0100
ARKG 6 Oct 2021 Sell IOVA IOVANCE BIOTHERAPEUTICS INC 65,866 0.0300
ARKG 6 Oct 2021 Buy DYNS DYNAMICS SPECIAL PURPOSE CORP 600 0.0000
ARKG 6 Oct 2021 Buy DNA GINKGO BIOWORKS HOLDINGS INC 1,525,065 0.2200
ARKG 6 Oct 2021 Buy BEAM BEAM THERAPEUTICS INC 75,862 0.0900
ARKG 6 Oct 2021 Buy ADPT ADAPTIVE BIOTECHNOLOGIES CORP 103,497 0.0500
ARKG 5 Oct 2021 Sell VRTX VERTEX PHARMACEUTICALS INC 40,413 0.1058
ARKG 5 Oct 2021 Buy SURF SURFACE ONCOLOGY INC 188,676 0.0211
ARKG 5 Oct 2021 Sell SMFR SEMA4 HOLDINGS CORP 2,453 0.0003
ARKG 5 Oct 2021 Buy SLGC SOMALOGIC INC 80,200 0.0135
ARKG 5 Oct 2021 Buy SGFY SIGNIFY HEALTH INC 391,069 0.1008
ARKG 5 Oct 2021 Sell SDGR SCHRODINGER INC/UNITED STATES 8,800 0.0067
ARKG 5 Oct 2021 Sell REGN REGENERON PHARMACEUTICALS INC 19,128 0.1545
ARKG 5 Oct 2021 Buy QSI QUANTUM-SI INC 119,754 0.0143
ARKG 5 Oct 2021 Buy PACB PACIFIC BIOSCIENCES OF CALIFORNIA INC 124,974 0.0456
ARKG 5 Oct 2021 Buy MASS 908 DEVICES INC 18,000 0.0089
ARKG 5 Oct 2021 Buy DYNS DYNAMICS SPECIAL PURPOSE CORP 204 0.0000
ARKG 5 Oct 2021 Sell CLLS CELLECTIS SA 23,802 0.0044
ARKG 5 Oct 2021 Buy BEAM BEAM THERAPEUTICS INC 12,094 0.0149
ARKG 5 Oct 2021 Buy ADPT ADAPTIVE BIOTECHNOLOGIES CORP 105,175 0.0504
ARKG 1 Oct 2021 Buy VCYT VERACYTE INC 12,044 0.0078
ARKG 1 Oct 2021 Buy SURF SURFACE ONCOLOGY INC 141,079 0.0153
ARKG 1 Oct 2021 Sell SMFR SEMA4 HOLDINGS CORP 250,989 0.0265
ARKG 1 Oct 2021 Sell SDGR SCHRODINGER INC/UNITED STATES 9,300 0.0071
ARKG 1 Oct 2021 Buy QSI QUANTUM-SI INC 104,334 0.0120
ARKG 1 Oct 2021 Buy PSNL PERSONALIS INC 47,070 0.0125
ARKG 1 Oct 2021 Buy DNA GINKGO BIOWORKS HOLDINGS INC 1,824,367 0.2917
ARKG 1 Oct 2021 Buy CRSP CRISPR THERAPEUTICS AG 26,000 0.0405
ARKG 1 Oct 2021 Sell CLLS CELLECTIS SA 8,721 0.0015
ARKG 1 Oct 2021 Sell CDXS CODEXIS INC 942,947 0.3461
ARKG 1 Oct 2021 Buy BEAM BEAM THERAPEUTICS INC 38,636 0.0468
ARKG 29 Sep 2021 Buy SURF SURFACE ONCOLOGY INC 252,503 0.0259
ARKG 29 Sep 2021 Sell SDGR SCHRODINGER INC/UNITED STATES 20,937 0.0161
ARKG 29 Sep 2021 Buy QSI QUANTUM-SI INC 438,626 0.0535
ARKG 29 Sep 2021 Buy PSNL PERSONALIS INC 45,300 0.0115
ARKG 29 Sep 2021 Buy PACB PACIFIC BIOSCIENCES OF CALIFORNIA INC 170,327 0.0587
ARKG 29 Sep 2021 Buy DYNS DYNAMICS SPECIAL PURPOSE CORP 4,800 0.0007
ARKG 29 Sep 2021 Buy CRSP CRISPR THERAPEUTICS AG 22,000 0.0335
ARKG 29 Sep 2021 Sell CRBU CARIBOU BIOSCIENCES INC 114,402 0.0384
ARKG 29 Sep 2021 Buy BEAM BEAM THERAPEUTICS INC 56,108 0.0697
ARKG 28 Sep 2021 Buy VCYT VERACYTE INC 17,900 0.0110
ARKG 28 Sep 2021 Buy SURF SURFACE ONCOLOGY INC 29,144 0.0028
ARKG 28 Sep 2021 Buy SGFY SIGNIFY HEALTH INC 402,747 0.1039
ARKG 28 Sep 2021 Sell SDGR SCHRODINGER INC/UNITED STATES 97,947 0.0723
ARKG 28 Sep 2021 Buy QSI QUANTUM-SI INC 398,229 0.0467
ARKG 28 Sep 2021 Buy PACB PACIFIC BIOSCIENCES OF CALIFORNIA INC 80,479 0.0265
ARKG 28 Sep 2021 Buy NVTA INVITAE CORP 17,180 0.0066
ARKG 28 Sep 2021 Sell NVS NOVARTIS AG 320,220 0.3484
ARKG 28 Sep 2021 Buy MASS 908 DEVICES INC 8,500 0.0037
ARKG 28 Sep 2021 Buy CRSP CRISPR THERAPEUTICS AG 10,500 0.0158
ARKG 28 Sep 2021 Sell CRBU CARIBOU BIOSCIENCES INC 239,900 0.0764
ARKG 28 Sep 2021 Sell CLLS CELLECTIS SA 700 0.0001
ARKG 28 Sep 2021 Buy BEAM BEAM THERAPEUTICS INC 27,345 0.0332
ARKG 27 Sep 2021 Sell SMFR SEMA4 HOLDINGS CORP 1,200 0.0001
ARKG 27 Sep 2021 Buy QSI QUANTUM-SI INC 33,592 0.0039
ARKG 27 Sep 2021 Sell NVS NOVARTIS AG 107,020 0.1152
ARKG 27 Sep 2021 Buy MASS 908 DEVICES INC 64,016 0.0278
ARKG 27 Sep 2021 Sell CSTL CASTLE BIOSCIENCES INC 11,200 0.0104
ARKG 27 Sep 2021 Sell CRBU CARIBOU BIOSCIENCES INC 39,860 0.0125
ARKG 27 Sep 2021 Sell CLLS CELLECTIS SA 24,503 0.0043
ARKG 27 Sep 2021 Sell CDXS CODEXIS INC 1,200 0.0004
ARKG 27 Sep 2021 Buy BEAM BEAM THERAPEUTICS INC 93,398 0.1142
ARKG 24 Sep 2021 Sell SMFR SEMA4 HOLDINGS CORP 80,700 0.0085
ARKG 24 Sep 2021 Buy QSI QUANTUM-SI INC 241,956 0.0270
ARKG 24 Sep 2021 Buy NVTA INVITAE CORP 188,391 0.0731
ARKG 24 Sep 2021 Sell CRBU CARIBOU BIOSCIENCES INC 70,400 0.0229
ARKG 24 Sep 2021 Sell CLLS CELLECTIS SA 200 0.0000
ARKG 23 Sep 2021 Sell SMFR SEMA4 HOLDINGS CORP 19,527 0.0020
ARKG 23 Sep 2021 Buy SGFY SIGNIFY HEALTH INC 500,056 0.1277
ARKG 23 Sep 2021 Buy QSI QUANTUM-SI INC 35,000 0.0040
ARKG 23 Sep 2021 Sell NVS NOVARTIS AG 157,464 0.1674
ARKG 23 Sep 2021 Sell CLLS CELLECTIS SA 7,628 0.0013
ARKG 23 Sep 2021 Sell CDXS CODEXIS INC 16,760 0.0055
ARKG 22 Sep 2021 Buy TDOC TELADOC HEALTH INC 49,572 0.0868
ARKG 22 Sep 2021 Sell SMFR SEMA4 HOLDINGS CORP 12,280 0.0013
ARKG 22 Sep 2021 Buy SGFY SIGNIFY HEALTH INC 663,604 0.1913
ARKG 22 Sep 2021 Buy NVTA INVITAE CORP 147,384 0.0594
ARKG 22 Sep 2021 Sell NVS NOVARTIS AG 241,747 0.2533
ARKG 22 Sep 2021 Sell CLLS CELLECTIS SA 12,212 0.0021
ARKG 22 Sep 2021 Sell CDXS CODEXIS INC 126,224 0.0405
ARKG 22 Sep 2021 Sell BMY BRISTOL-MYERS SQUIBB CO 11,930 0.0091
ARKG 22 Sep 2021 Buy BEAM BEAM THERAPEUTICS INC 917 0.0011
ARKG 21 Sep 2021 Buy TDOC TELADOC HEALTH INC 90,387 0.1594
ARKG 21 Sep 2021 Sell SMFR SEMA4 HOLDINGS CORP 236,370 0.0262
ARKG 21 Sep 2021 Buy SLGC SOMALOGIC INC 100 0.0000
ARKG 21 Sep 2021 Buy PSNL PERSONALIS INC 98,918 0.0264
ARKG 21 Sep 2021 Buy NVTA INVITAE CORP 91,848 0.0370
ARKG 21 Sep 2021 Sell NVS NOVARTIS AG 94,000 0.0990
ARKG 21 Sep 2021 Sell CRBU CARIBOU BIOSCIENCES INC 275,182 0.0850
ARKG 21 Sep 2021 Sell CLLS CELLECTIS SA 4,696 0.0008
Latest Blogs
Is Cathie Wood's winning streak coming to an end? In the third quarter, Ark Invest ETFs underperformed a broader market

Even while other actively managed funds and fund managers battled to recover from the COVID-19-induced slowdown, Cathie Wood's Ark Invest had a spectacular year in 2020. Wood was dubbed the "Midas Touch" after her fund's flagship ARK Innovation ETF ARKK +0.77% (Get Free Alerts for ARKK) returned a whopping 153 percent, outperforming the S& P 500 Index's 16.3 percent gain.

Ark Experiences a Post-COVID-19 Complication: By 2021, Ark's performance had become more mixed. The Ark Innovation ETF dropped 3.7 percent in the first quarter before rebounding with a 9 percent gain in the second.

According to Ark's third-quarter performance report, all of its actively managed funds and its two self-indexed ETFs underperformed the market.

The performance of each Ark ETF in the third quarter is as follows:

 

ETFs that are actively traded

ETF: Ark Innovation: (-15.5 percent )

The Ark Autonomous Technology & Robotics ETF (ARKQ) is an exchange-traded fund that invests in autonomous technology and robotics (-9.5 percent )

The Ark Next Generation Internet ETF (ARKW) is an exchange-traded fund that invests in the next generation of the internet (-9.9 percent )

ETF for the Ark Genomic Revolution (ARKG): (-19.3 percent )

ARK Fintech Innovation ETF ARKF +0.06%: ARK Fintech Innovation ETF ARKF +0.06%: ARK Fintech Innovation ETF ARK (-8.7 percent )

ARK Space Exploration & Innovation ETF (ARKX): Ark ETF Trust: (-6.6 percent )

ETFs that track indices

The ETF for 3D Printing (PRNT): (-10 percent )

The Ark Israel Innovation Technology ETF (IZRL) is a mutual fund that invests in Israel's innovative technology (-8.3 percent )

When compared to the more significant market performance, the low showing is exemplified. The S& P 500 Index rose 2.5 percent in the third quarter, while the Nasdaq Composite Index rose 5.1 percent.

Consumer and investor confidence is being harmed by macro headwinds, according to Wood's quarterly report. Fears of an economic slowdown arose due to a spike in the delta strain of the coronavirus, supply chain difficulties, and a Chinese government crackdown, she noted.

Ark feels that inflation fears are exaggerated and that the chances of deflation are more plausible.

Will Bitcoin Be Banned In The United States Like Gold Was? Cathie Wood and Ark Invest weigh in.

 

Tesla Aids In Weakness Mitigation: Wood is a self-proclaimed Tesla, Inc. TSLA +3.26 percent bull. With over 10% stakes in each, Tesla is part of the ARK Innovation ETF, the Ark Innovation ETF, and the Ark Innovation ETF.

In the third quarter, the electric vehicle behemoth topped the list of contributors to the returns of each of these ETFs.

Ark Invest sold approximately $605 million of Tesla stock in September alone, taking advantage of the EV maker's third-quarter rally.

Tesla's sales have continued far into October.

Energy and financial services are the most likely to be disrupted by innovation. The power and financial services sectors have benefited the most from the shift toward cyclical in the last nine to 12 months, according to Ark. These two industries, according to the firm, will be the most disrupted by innovation during the next five years.

"Autonomous electric vehicles and digital wallets, including cryptocurrencies and the decentralized financial services (DeFi) associated more broadly with blockchain technologies, will, in ARK's opinion, significantly disrupt and disintermediate both Energy and Financial Services over the next five years."

 

Cathie Wood, the founder of Ark Invest, did not purchase the first Bitcoin futures ETF.

According to Business Insider, Ark Invest founder and CEO Cathie Wood did not invest in the ProShares Bitcoin Strategy exchange-traded fund (ETF) on its first day.

Wood had this to say regarding the ETF's debut:

"We did not [invest]," says the narrator. We're taking a close look at this [...] there are specific tax implications we'd like to learn more about in terms of contango versus more traditional backwardation."

When the future price is greater than the current price, the ETF is in contango. In a negative trend, backwardation occurs when the forward price of a futures contract is lower than the spot price.

In June, wood's Ark Invest teamed up with 21 Shares to file for its Bitcoin (BTC) ETF. When it comes to investing in cryptocurrencies, she is also no stranger to the stock market.

Ark Investment Management, one of her funds, has been permitted to invest in Canada's Bitcoin ETF, the Ark Next Generation ETF. Grayscale Bitcoin Trust (GBTC) has 8.3 million shares, with Bitcoin and Ether (ETH) accounting for a significant portion of Ark Invest's portfolio.

Ark Invest also added Coinbase stock to three of its ETFs in the spring, including the Ark Innovation ETF (ARKK), the Ark Next Generation Internet ETF (ARKW), and the Ark Fintech Innovation ETF (ARKF).

Wood stated that she is on the lookout for the next FAANG investment that will benefit her investors. FAANG is an abbreviation for the five largest American technology companies: Facebook, Amazon, Apple, Netflix, and Google. Jim Cramer first invented the phrase "FAANG" in 2013.

On its first day of trading, the Bitcoin Strategy ETF recorded the highest natural volume of any ETF and the second-highest overall volume.

 

Cathie Wood's Ark Invest is leaving Wall Street and relocating to Florida

Ark Investment Management said on Wednesday that it is permanently closing its New York office and relocating to St. Petersburg, Florida.

In 2020, Wood's flagship Ark Innovation exchange-traded fund soared over 150 percent, making her a Wall Street sensation.

Wood is unique in that she focuses solely on the technology industry. So it's probably unsurprising that she's quitting Wall Street.

Ark expects the move to "advance its business as it scales and continues to alter the asset management market," as well as "improve collaboration between and across the communities focused on innovation," according to the company.

"Ark isn't your typical Wall Street asset management firm, and we're excited to continue to break the mold by relocating to St. Petersburg, a city that values technology, research, and creativity," Wood added.

Jana Haines, Ark's strategy chief, said the area's "vibrant and diversified talent base" and the success of public-private partnerships centered on innovation encouraged the company.

This year hasn't been as good to Wood as the previous one. Despite a booming tech market, with the Nasdaq up more than 14 percent so far in 2021, the Innovation ETF is down 3.5 percent coming into the fourth quarter.